349 related articles for article (PubMed ID: 23382250)
1. L-acetylcarnitine causes rapid antidepressant effects through the epigenetic induction of mGlu2 receptors.
Nasca C; Xenos D; Barone Y; Caruso A; Scaccianoce S; Matrisciano F; Battaglia G; Mathé AA; Pittaluga A; Lionetto L; Simmaco M; Nicoletti F
Proc Natl Acad Sci U S A; 2013 Mar; 110(12):4804-9. PubMed ID: 23382250
[TBL] [Abstract][Full Text] [Related]
2. Transcriptional regulation of metabotropic glutamate receptor 2/3 expression by the NF-kappaB pathway in primary dorsal root ganglia neurons: a possible mechanism for the analgesic effect of L-acetylcarnitine.
Chiechio S; Copani A; De Petris L; Morales ME; Nicoletti F; Gereau RW
Mol Pain; 2006 Jun; 2():20. PubMed ID: 16764720
[TBL] [Abstract][Full Text] [Related]
3. The group II mGlu receptor antagonist LY341495 induces a rapid antidepressant-like effect and enhances the effect of ketamine in the chronic unpredictable mild stress model of depression in C57BL/6J mice.
Pałucha-Poniewiera A; Podkowa K; Rafało-Ulińska A
Prog Neuropsychopharmacol Biol Psychiatry; 2021 Jul; 109():110239. PubMed ID: 33400944
[TBL] [Abstract][Full Text] [Related]
4. L-Acetylcarnitine induces analgesia by selectively up-regulating mGlu2 metabotropic glutamate receptors.
Chiechio S; Caricasole A; Barletta E; Storto M; Catania MV; Copani A; Vertechy M; Nicolai R; Calvani M; Melchiorri D; Nicoletti F
Mol Pharmacol; 2002 May; 61(5):989-96. PubMed ID: 11961116
[TBL] [Abstract][Full Text] [Related]
5. Next generation antidepressants.
Russo SJ; Charney DS
Proc Natl Acad Sci U S A; 2013 Mar; 110(12):4441-2. PubMed ID: 23471996
[No Abstract] [Full Text] [Related]
6. Antidepressant-like actions of the mGlu2/3 receptor antagonist TP0178894 in the chronic social defeat stress model: Comparison with escitalopram.
Dong C; Tian Z; Fujita Y; Fujita A; Hino N; Iijima M; Hashimoto K
Pharmacol Biochem Behav; 2022 Jan; 212():173316. PubMed ID: 34968554
[TBL] [Abstract][Full Text] [Related]
7. The Rapidly Acting Antidepressant Ketamine and the mGlu2/3 Receptor Antagonist LY341495 Rapidly Engage Dopaminergic Mood Circuits.
Witkin JM; Monn JA; Schoepp DD; Li X; Overshiner C; Mitchell SN; Carter G; Johnson B; Rasmussen K; Rorick-Kehn LM
J Pharmacol Exp Ther; 2016 Jul; 358(1):71-82. PubMed ID: 27189960
[TBL] [Abstract][Full Text] [Related]
8. Requirement of AMPA receptor stimulation for the sustained antidepressant activity of ketamine and LY341495 during the forced swim test in rats.
Koike H; Chaki S
Behav Brain Res; 2014 Sep; 271():111-5. PubMed ID: 24909673
[TBL] [Abstract][Full Text] [Related]
9. Upregulation of mGlu2 receptors via NF-κB p65 acetylation is involved in the Proneurogenic and antidepressant effects of acetyl-L-carnitine.
Cuccurazzu B; Bortolotto V; Valente MM; Ubezio F; Koverech A; Canonico PL; Grilli M
Neuropsychopharmacology; 2013 Oct; 38(11):2220-30. PubMed ID: 23670591
[TBL] [Abstract][Full Text] [Related]
10. Epigenetics and energetics in ventral hippocampus mediate rapid antidepressant action: Implications for treatment resistance.
Bigio B; Mathé AA; Sousa VC; Zelli D; Svenningsson P; McEwen BS; Nasca C
Proc Natl Acad Sci U S A; 2016 Jul; 113(28):7906-11. PubMed ID: 27354525
[TBL] [Abstract][Full Text] [Related]
11. Group II metabotropic glutamate receptor blockade promotes stress resilience in mice.
Highland JN; Zanos P; Georgiou P; Gould TD
Neuropsychopharmacology; 2019 Sep; 44(10):1788-1796. PubMed ID: 30939596
[TBL] [Abstract][Full Text] [Related]
12. Analgesia induced by the epigenetic drug, L-acetylcarnitine, outlasts the end of treatment in mouse models of chronic inflammatory and neuropathic pain.
Notartomaso S; Mascio G; Bernabucci M; Zappulla C; Scarselli P; Cannella M; Imbriglio T; Gradini R; Battaglia G; Bruno V; Nicoletti F
Mol Pain; 2017 Jan; 13():1744806917697009. PubMed ID: 28326943
[TBL] [Abstract][Full Text] [Related]
13. Physiological antagonism between 5-hydroxytryptamine(2A) and group II metabotropic glutamate receptors in prefrontal cortex.
Marek GJ; Wright RA; Schoepp DD; Monn JA; Aghajanian GK
J Pharmacol Exp Ther; 2000 Jan; 292(1):76-87. PubMed ID: 10604933
[TBL] [Abstract][Full Text] [Related]
14. 5-HT
Fukumoto K; Iijima M; Funakoshi T; Chaki S
Neuropharmacology; 2018 Jul; 137():96-103. PubMed ID: 29738849
[TBL] [Abstract][Full Text] [Related]
15. Metabotropic glutamate 2/3 receptor antagonists improve behavioral and prefrontal dopaminergic alterations in the chronic corticosterone-induced depression model in mice.
Ago Y; Yano K; Araki R; Hiramatsu N; Kita Y; Kawasaki T; Onoe H; Chaki S; Nakazato A; Hashimoto H; Baba A; Takuma K; Matsuda T
Neuropharmacology; 2013 Feb; 65():29-38. PubMed ID: 23022081
[TBL] [Abstract][Full Text] [Related]
16. Serotonin-1A receptor stimulation mediates effects of a metabotropic glutamate 2/3 receptor antagonist, 2S-2-amino-2-(1S,2S-2-carboxycycloprop-1-yl)-3-(xanth-9-yl)propanoic acid (LY341495), and an N-methyl-D-aspartate receptor antagonist, ketamine, in the novelty-suppressed feeding test.
Fukumoto K; Iijima M; Chaki S
Psychopharmacology (Berl); 2014 Jun; 231(11):2291-8. PubMed ID: 24402133
[TBL] [Abstract][Full Text] [Related]
17. mGlu
Joffe ME; Santiago CI; Oliver KH; Maksymetz J; Harris NA; Engers JL; Lindsley CW; Winder DG; Conn PJ
Neuron; 2020 Jan; 105(1):46-59.e3. PubMed ID: 31735403
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of 5-HT2A and mGlu2/3 receptors in postmortem prefrontal cortex of subjects with major depressive disorder: effect of antidepressant treatment.
Muguruza C; Miranda-Azpiazu P; Díez-Alarcia R; Morentin B; González-Maeso J; Callado LF; Meana JJ
Neuropharmacology; 2014 Nov; 86():311-8. PubMed ID: 25150943
[TBL] [Abstract][Full Text] [Related]
19. Stress dynamically regulates behavior and glutamatergic gene expression in hippocampus by opening a window of epigenetic plasticity.
Nasca C; Zelli D; Bigio B; Piccinin S; Scaccianoce S; Nisticò R; McEwen BS
Proc Natl Acad Sci U S A; 2015 Dec; 112(48):14960-5. PubMed ID: 26627246
[TBL] [Abstract][Full Text] [Related]
20. Defective group-II metaboropic glutamate receptors in the hippocampus of spontaneously depressed rats.
Matrisciano F; Caruso A; Orlando R; Marchiafava M; Bruno V; Battaglia G; Gruber SH; Melchiorri D; Tatarelli R; Girardi P; Mathè AA; Nicoletti F
Neuropharmacology; 2008 Sep; 55(4):525-31. PubMed ID: 18590921
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
